Aller au contenu

Interactions médicamenteuses

Dabigatran etexilate + Erdafitinib

Gravité: Majeure

Dabigatran etexilate and Erdafitinib: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Erdafitinib inhibits P-glycoprotein and may increase the absorption of dabigatran, a P-gp substrate. Higher dabigatran concentrations raise the risk of bleeding, particularly with renal impairment.

Ce que signifie cette interaction, en termes simples

Dabigatran etexilate and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dabigatran etexilate belongs to Cardiovascular; Erdafitinib belongs to Oncology.

Niveau de preuve: Moderate

Pourquoi elle survient

Inhibition of intestinal P-gp efflux by erdafitinib increases dabigatran bioavailability.

Conduite à tenir

If coadministration is unavoidable, take dabigatran at least 6 hours before or after erdafitinib and monitor for bleeding. Check renal function and consider a dabigatran dose reduction or alternative anticoagulant when renal function is impaired.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Dabigatran etexilate et Erdafitinib, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.

Questions fréquentes

Can I take Dabigatran etexilate with Erdafitinib?

MediHelp rates the interaction as major. Dabigatran etexilate and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Erdafitinib inhibits P-glycoprotein and may increase the absorption of dabigatran, a P-gp substrate. Higher dabigatran concentrations raise the risk of bleeding, particularly with renal impairment.

How serious is the interaction between Dabigatran etexilate and Erdafitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If coadministration is unavoidable, take dabigatran at least 6 hours before or after erdafitinib and monitor for bleeding. Check renal function and consider a dabigatran dose reduction or alternative anticoagulant when renal function is impaired.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter